Home >> Tag Archives: Affymetrix—

Tag Archives: Affymetrix—

Affymetrix fetches $1.3 billion from Thermo Fisher

Jan. 12, 2016—Thermo Fisher Scientific will buy cellular and genetics analysis products company Affymetrix for $14 per share in cash, which represents a purchase price of about $1.3 billion. Affymetrix’s technologies enable parallel and multiplex analysis of biological systems at the cellular, protein, and genetic level, facilitating the transition of research tools into clinical and applied markets. The company’s products ...

Read More »

Affymetrix, XRGenomics join forces

Nov. 25, 2015—Affymetrix and XRGenomics, UK-based biotechnology company, announced that they will collaborate on research and development of a new generation of diagnostic tests for age-related diseases. XRGenomics has used Affymetrix technology to develop novel gene expression-based signatures that enable translational research and biomarker test development activities in areas such as dementia, Alzheimer disease, and other age-related diseases. XRGenomics officials hope ...

Read More »

Affymetrix, Ariosa Diagnostics sign supply agreement, 12/14

December 2014—Affymetrix and Ariosa Diagnostics announced the signing of a multiyear supply agreement covering Affymetrix arrays and instruments to be used as part of Ariosa’s Harmony Non-Invasive Prenatal Test. The partnership enables Ariosa to pursue the development of a Harmony test kit that will allow laboratories worldwide to adopt and perform this test.

Read More »

FDA clears CytoScan Dx, 3/14

March 2014—Affymetrix received FDA 510(k) clearance to market its CytoScan Dx assay, intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. Cyto­Scan Dx is designed to help diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution, genome-wide analysis of genetic aberrations.

Read More »

Customized system for cytogenetics assay, 4/13:88

Hamilton Robotics announced that the CytoScan automated target preparation solution from Affymetrix is built on Hamilton’s customizable Microlab Nimbus 96 workstation. The Nimbus 96 instrument automates target preparation for the CytoScan cytogenetics solution, which offers broad coverage for detecting human chromosomal aberrations.

Read More »